Gastrointestinal immune and microbiome changes during parenteral nutrition
- PMID: 28154012
- PMCID: PMC5401992
- DOI: 10.1152/ajpgi.00321.2016
Gastrointestinal immune and microbiome changes during parenteral nutrition
Abstract
Parenteral nutrition (PN) is a lifesaving therapy that provides intravenous nutrition support to patients who cannot, or should not, feed via the gastrointestinal (GI) tract. Unfortunately, PN also carries certain risks related to infection and metabolic complications compared with enteral nutrition. In this review, an overview of PN and GI immune and microbiome changes is provided. PN impacts the gut-associated lymphoid tissue functions, especially adaptive immune cells, changes the intestinal epithelium and chemical secretions, and significantly alters the intestinal microbiome. Collectively, these changes functionally result in increased susceptibility to infectious and injurious challenge. Since PN remains necessary in large numbers of patients, the search to improve outcomes by stimulating GI immune function during PN remains of interest. This review closes by describing recent advances in using enteric nervous system neuropeptides or microbially derived products during PN, which may improve GI parameters by maintaining immunity and physiology.
Keywords: GALT; Paneth cells; enteral nutrition; gastrointestinal immunity; microbiome; mucosal immunity; parenteral nutrition; sIgA.
Copyright © 2017 the American Physiological Society.
Figures
Similar articles
-
Parenteral nutrition decreases paneth cell function and intestinal bactericidal activity while increasing susceptibility to bacterial enteroinvasion.JPEN J Parenter Enteral Nutr. 2014 Sep;38(7):817-824. doi: 10.1177/0148607113497514. Epub 2013 Jul 26. JPEN J Parenter Enteral Nutr. 2014. PMID: 23894173 Free PMC article.
-
Parenteral nutrition impairs gut-associated lymphoid tissue and mucosal immunity by reducing lymphotoxin Beta receptor expression.Ann Surg. 2006 Sep;244(3):392-9. doi: 10.1097/01.sla.0000234797.42935.46. Ann Surg. 2006. PMID: 16926565 Free PMC article.
-
Reversal of parenteral nutrition-induced gut mucosal immunity impairment with small amounts of a complex enteral diet.J Trauma. 2008 Aug;65(2):360-5; discussion 366. doi: 10.1097/TA.0b013e31817c9711. J Trauma. 2008. PMID: 18695472
-
Changes to the Intestinal Microbiome With Parenteral Nutrition: Review of a Murine Model and Potential Clinical Implications.Nutr Clin Pract. 2015 Dec;30(6):798-806. doi: 10.1177/0884533615609904. Epub 2015 Sep 30. Nutr Clin Pract. 2015. PMID: 26424591 Review.
-
Parenteral Nutrition-Associated Liver Disease: The Role of the Gut Microbiota.Nutrients. 2017 Sep 7;9(9):987. doi: 10.3390/nu9090987. Nutrients. 2017. PMID: 28880224 Free PMC article. Review.
Cited by
-
Metabolic programming of the epigenome: host and gut microbial metabolite interactions with host chromatin.Transl Res. 2017 Nov;189:30-50. doi: 10.1016/j.trsl.2017.08.005. Epub 2017 Sep 1. Transl Res. 2017. PMID: 28919341 Free PMC article. Review.
-
Parenteral Nutrition, Inflammatory Bowel Disease, and Gut Barrier: An Intricate Plot.Nutrients. 2024 Jul 17;16(14):2288. doi: 10.3390/nu16142288. Nutrients. 2024. PMID: 39064731 Free PMC article. Review.
-
Surgical Intervention Strategies of Necrotizing Pancreatitis With Abdominal Compartment Syndrome.Pancreas. 2021 Nov-Dec 01;50(10):1415-1421. doi: 10.1097/MPA.0000000000001949. Pancreas. 2021. PMID: 35041341 Free PMC article.
-
Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance.Front Immunol. 2021 Mar 16;12:644982. doi: 10.3389/fimmu.2021.644982. eCollection 2021. Front Immunol. 2021. PMID: 33815399 Free PMC article. Review.
-
A scoring system based on novel biomarkers and clinical risk factors to predict invasive candidiasis in immunocompetent critically ill patients.Front Microbiol. 2023 Mar 9;14:1097574. doi: 10.3389/fmicb.2023.1097574. eCollection 2023. Front Microbiol. 2023. PMID: 36970699 Free PMC article.
References
-
- Bergstrom KSB, Morampudi V, Chan JM, Bhinder G, Lau J, Yang H, Ma C, Huang T, Ryz N, Sham HP, Zarepour M, Zaph C, Artis D, Nair M, Vallance BA. Goblet cell derived RELM-β recruits CD4+ T cells during infectious colitis to promote protective intestinal epithelial cell proliferation. PLoS Pathog 11: e1005108, 2015. doi:10.1371/journal.ppat.1005108. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical